LUTATHERA Funded In British Columbia

By |2021-03-08T21:44:05+00:00March 8th, 2021|Treatment News|

CNETS is happy to announce that BC Cancer will now reimburse LUTATHERA for the approved indication. The BC Cancer Benefit Drug List, Published March 2021, Tumour Site: Gastrointestinal Peptide [...]

Comments Off on LUTATHERA Funded In British Columbia

INSPIRATIONAL NET CANCER PATIENT STORY

By |2021-02-11T19:05:18+00:00February 11th, 2021|News|

INSPIRATIONAL NEUROENDOCRINE CANCER PATIENT STORY Long-time CNETS fundraisers Bryde Fresque and Natalie Mezey, share a message of hope! As outlined in this Ottawa Hospital Foundation report, Bryde Fresque [...]

Comments Off on INSPIRATIONAL NET CANCER PATIENT STORY

ESMO Guidelines: Lung & Thymic Carcinoids

By |2021-02-04T06:28:24+00:00February 4th, 2021|Publication|

Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Published January 19, 2021 Highlights This updated ESMO Clinical Practice Guideline [...]

Comments Off on ESMO Guidelines: Lung & Thymic Carcinoids

European Journal of Cancer Article

By |2021-01-05T11:18:58+00:00January 5th, 2021|Research|

Article: Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era February 2021 - European Journal of Cancer, Review [...]

Comments Off on European Journal of Cancer Article

INCA NETInfo

By |2020-12-26T03:59:28+00:00December 26th, 2020|Education|

INCA GLOBAL NET PATIENT INFO PACK NEW FOR 2020! - NETInfo INCA launches a range of factsheets on NETs that are free to download. These factsheets provide [...]

Comments Off on INCA NETInfo

LUTATHERA® Funded in Ontario

By |2020-10-10T14:14:05+00:00October 10th, 2020|Treatment News|

Radiopharmaceutical cancer treatment Lutathera® now available to Ontario patients with midgut neuroendocrine tumours (NETs). The Ontario funding criteria covers the treatment of adult patients with somatostatin receptor-positive (SSR+) midgut NETs [...]

Comments Off on LUTATHERA® Funded in Ontario

LUTATHERA® Funded in Quebec

By |2020-10-03T15:46:51+00:00October 3rd, 2020|Treatment News|

As of September 30, 2020, the Québec Ministry of Health and Social Services has listed Lutathera on the Liste de Médicaments – Établissements. Lutathera will be reimbursed for GEP-NETs patients [...]

Comments Off on LUTATHERA® Funded in Quebec

LUTATHERA® Funded in Nova Scotia

By |2020-09-06T16:03:58+00:00September 4th, 2020|Treatment News|

As of August 1, 2020, patients with midgut, GEP-NETs will now be eligible for treatment with LUTATHERA® [lutetium (177Lu) oxodotreotide]. This listing covers adult patients with somatostatin receptor-positive (SSR+) midgut [...]

Comments Off on LUTATHERA® Funded in Nova Scotia

#HoofingIt launches at Peggy’s Cove July 1

By |2020-07-03T01:17:10+00:00July 3rd, 2020|News|

HOOFING IT - The summer-long fundraiser launched at Peggy's Cove on July 1st. Sharon Needham, lung neuroendocrine cancer survivor and advocate; family, friends, supporters kicked-off HOOFING IT with a [...]

Comments Off on #HoofingIt launches at Peggy’s Cove July 1
Go to Top